Biomarkers of Ischemia: Xanthine, Hypoxanthine and Inosine Levels During Carotid Stenting Procedures

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

10 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-03-31

Study Completion Date

2013-10-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study is to determine if a new blood test can help the doctor determine if there is brain injury or ischemia. Ischemia occurs when not enough oxygen gets to the brain. In this study the investigators are analyzing your blood for a new test that might help doctors decide if symptoms are from a neurologic problem.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.

NCT01609569

Coronary Disease

UNKNOWN

Point of Care (POC) Biomarkers of Ischemia

NCT02039882

Acute Coronary Syndrome Myocardial Infarction

COMPLETED

Detection of Coronary Stenosis With Intravenous Microbubbles

NCT00580580

Coronary Stenosis Carotid Stenosis Myocardial Reperfusion

WITHDRAWN NA

Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke Patients

NCT03925298

Cerebrovascular Accident

COMPLETED

Biomarkers for Cardiovascular Disease

NCT00109018

Coronary Artery Disease

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

We will compare a new blood test with routine tests that the doctor will order as part of your normal care. This study will measure new biomarkers (biomarker is a specific distinguishing feature used to measure or indicate the effects or progress of a disease or condition) of neurologic stress called xanthine, hypoxanthine, and inosine. Blood will be drawn as a part of the study to measure these biomarker levels in your blood. This blood will be analyzed i the laboratory at Virginia Commonwealth University and possibly at a future date at another institution. No names will be associated with the blood sample

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Identify the Presence of a Marker of Ischemia/Hypoperfusion of the Brain Via Peripheral Blood Ischemia/Hypoperfusion of Brain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Biomarkers, Carotid Stenting, Blood sample

Subjects requiring Carotid Stenting Procedure at Virginia Commonwealth University/Medical College of Virginia Health Systems

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and Women over age of 18 non
* Women who are not pregnant
* Subject who are not prisoners
* Subjects presenting to the operation room for a Carotid artery stenting procedure
* Hemoglobin greater than or equal to 11mg/dl
* Subjects who speak english
* Subjects 18 years of age or older